Form 4: TransMedics Group Director James R. Tobin Acquires Shares and Stock Options
SEC Form 4
Director James R. Tobin reported the acquisition of common stock and stock options in TransMedics Group, Inc.
Summary
- On May 23, 2024, James R. Tobin, a director of TransMedics Group, Inc., acquired 732 shares of common stock in the form of restricted stock units (RSUs) at a price of $0.00.
- Each RSU represents a contingent right to receive one share of TransMedics Group's common stock.
- Tobin also acquired 1,154 stock options with an exercise price of $137.53, exercisable starting May 23, 2025, and expiring on May 23, 2034.
- Following these transactions, Tobin directly owns 1,925 shares of common stock and indirectly owns 193,146 shares through the James R. Tobin 2012 Trust.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It reflects standard insider trading activity. The director's acquisition of shares and options could be interpreted as a positive sign, but it's a routine transaction.
Positives
- The acquisition of shares and stock options by a director could be seen as a positive signal, indicating confidence in the company's future prospects.
Industry Context
This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. These transactions are closely monitored by investors for insights into management's perspective on the company's valuation and future performance.
Stakeholder Impact
- The transaction may have a minor positive impact on shareholder sentiment, as insider purchases are often viewed favorably.
Key Dates
| Date | Description |
|---|---|
| 05/23/2024 | Date of transaction: Acquisition of common stock (RSUs) and stock options. |
| 05/23/2025 | Vesting date for the stock options, or the date of the 2025 annual meeting. |
| 05/23/2034 | Expiration date for the stock options. |
| 05/28/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.